SCHEMBL7740065

SCHEMBL7740065

COc1cc(CC(=O)NCc2ccccc2)c2c(c1)[nH]c(=O)n2Cc1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.50
NPC1 O15118 2/20 0.46
RECQL P46063 1/20 0.45
HTT P42858 1/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TSHR P16473 1/20 0.44
PDE2A O00408 1/20 0.44
PTPN1 P18031 1/20 0.43
TP53 P04637 3/20 0.43
BACE1 P56817 1/20 0.43
MCL1 Q07820 1/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739420 0.91 MAPT (0.50) MAPTNPC1TSHRPDE2ATP53
SCHEMBL7742335 0.89 MAPT (0.52) MAPTNPC1RECQLCYP3A4CYP2C9
SCHEMBL7739350 0.87 KDM4E (0.43) MAPTHTTKMT2AKDM4EMEN1
SCHEMBL7740742 0.83 KMT2A (0.50) MAPTTP53KMT2AKDM4EMEN1
SCHEMBL7739561 0.82 KDM4E (0.42) HTTCYP3A4CYP2C9NPSR1KMT2A
SCHEMBL7734611 0.77 POLB (0.40) MAPTHTTNPSR1KMT2AKDM4E
SCHEMBL7740373 0.77 KMT2A (0.43) MAPTHTTKMT2AKDM4EMEN1
SCHEMBL7734767 0.75 KDM4E (0.40) MAPTHTTTP53BACE1KMT2A
SCHEMBL7742329 0.74 ALDH1A1 (0.52) MAPTTP53KMT2AKDM4EMEN1
SCHEMBL7734708 0.74 KMT2A (0.42) MAPTHTTKMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420410-B1 ADMINISTERING N,N'-SUBSTITUTED BENZIMIDAZOL-2-ONES TO INDUCE APOPTOSIS IN NEOPLASTIC CELLS BUT NOT NORMAL CELLS; ANTICANCER, ANTITUMOR AGENT CELL PATHWAYS, INC. 2002-07-16 US disclosed